Precision Health

About Precision Health Initiative

A diagnosis of a complex disease like cancer or Alzheimer's can devastate patients and their families. The impact is widespread in Indiana: roughly two in five Hoosiers will eventually develop cancer. Today, we have every reason for hope in the face of these diagnoses—thanks to biomedical innovators. The Precision Health Initiative (PHI) is bringing some of these innovations to Hoosier patients. PHI builds on IU's legacy of biomedical breakthroughs—like the structure of DNA—to transform health through the application of research results.


Cure at least one cancer

Childhood Disease

Cure at least one childhood disease

Chronic Illness

Find a preventative solution to one chronic illness

Neurodegenerative Disease

Find a preventative solution to one neurodegenerative disease, like Alzheimer's

The Team

PHI is led by Anantha Shekhar, Associate Vice President for Clinical Affairs at IU and Executive Associate Dean for Research at the IU School of Medicine. PHI will enhance the prevention and treatment of disease by looking at all the factors that we now know impact an individual's health. Factors like lifestyle and genetics. Through a more precise analysis of these genetic, developmental, behavioral and environmental factors, PHI will establish and apply individualized treatment.

Though its objectives are bold, the approach is true to the process of scientific and medical discovery. To accomplish the Precision Health Initiative goals, Indiana University will:

  • Build new research programs and state-of-the-art facilities dedicated to precision health
  • Hire 39 new, full-time faculty members
  • Create new and expanded degree, certificate and professional medical education programs
  • Bring transformative, patient-centered therapies and prevention into clinical use in Indiana
  • Work closely with several prominent business and community partners, including Eli Lilly and Co., Roche Diagnostics, Cook Regentec, Deloitte, Regenstrief Institute and IU Health